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Nor98 scrapie identified in the United States
Christie M. Loiacono,1 Bruce V. Thomsen, S. Mark Hall, Matti Kiupel, Diane Sutton,
Katherine O’Rourke, Bradd Barr, Lucy Anthenill, Delwyn Keane
Abstract. A distinct strain of scrapie identified in sheep of Norway in 1998 has since been identified in
numerous countries throughout Europe. The disease is known as Nor98 or Nor98-like scrapie, among other
names. Distinctions between classic scrapie and Nor98 scrapie are made based on histopathology and
immunodiagnostic results. There are also differences in the epidemiology, typical signalment, and likelihood of
clinical signs being observed. In addition, sheep that have genotypes associated with resistance to classic
scrapie are not spared from Nor98 disease. The various differences between classic and Nor98 scrapie have
been consistently reported in the vast majority of cases described across Europe. The current study describes in
detail the pathologic changes and diagnostic results of the first 6 cases of Nor98 scrapie disease diagnosed in
sheep of the United States.
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Introduction
Scrapie is a fatal neurodegenerative disease that
affects the central nervous system of sheep and goats.
The presence of scrapie in the United States has an
important economic impact in that it prevents the
exportation of breeding stock, semen, and embryos to
many other countries (U.S. Department of Agriculture, Animal and Plant Health Inspection Service,
Veterinary Services: 2004, Scrapie, http://www.aphis.
usda.gov/lpa/pubs/fsheet_faq_notice/fs_ahscrapie.
pdf. Accessed on December 17, 2008). Multiple
strains of scrapie agent have been identified through
variation in incubation periods and neuropathology
in rodent models.4 The various scrapie agent strains
have also been found to differ in other ways,
including distribution in host tissues; lesion profiles;
and in prion protein conformation, glycosylation,
protease resistance, and protein aggregation.3,6,23
Another difference among scrapie agent strains is
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the variation in susceptibility among sheep of
different genetic makeup. The strain of the infecting
scrapie agent and the sequence of nucleotides on the
host prion gene are suspected to be major determinants of the transmission barrier. Four codons in the
ovine Prnp gene at positions 136, 141, 154, and 171
were identified as influencing the epidemiology of
classic and/or nonclassic scrapie.14,16–18,24
In 1998, a new and unique strain of scrapie agent
was found in sheep from Norway and was identified
as the Nor98 strain of scrapie.2 Since the first report
of Nor98 in 2003, this strain has been identified in
numerous countries, including Belgium, Germany,
France, Ireland, United Kingdom, Sweden, Portugal,
Netherlands, Lithuania, Italy, Estonia, Denmark,
Falkland Islands, Switzerland, Iceland, and Norway,5,7,9,11–13,19,20 and given various names, such as
Nor98-like, atypical, and nonclassic scrapie.1 More
recently, this strain has also been identified in goats.25
Despite the different names assigned to this strain of
scrapie agent, to date, no substrains have been
reported.
Differences are seen between classic scrapie and
Nor98 scrapie cases. Detection of PrPSc and the rare
manifestation of detectable central nervous system
signs associated with Nor98 scrapie infection generally occur in older sheep that range from 5 years of
age to over 10 years of age. Classic scrapie most often
affects sheep that range from 3 to 5 years of age.17
Clinical signs are uncommon with Nor98 scrapie,
however, when they are noted, they most often
include ataxia without pruritis.1 Sheep that have
genotypes associated with resistance to classic scrapie
are represented in the Nor98-infected population.8,16
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There are also differences in the distribution of PrPSc
in the central nervous system and the distinct protein
bands seen with Western blot techniques. The
diagnosis of Nor98 scrapie is based on immunohistochemical (IHC) identification of PrPSc in regions of
the brain including the cerebellum and spinal nucleus
of the trigeminal nerve while sparing the motor
nucleus of the vagus nerve and lymphoid tissues,
which are areas typically affected in classic scrapie.
Western blot results for Nor98 scrapie include a
multiple protein band pattern with an unglycosylated
band that measures ,15 kDa, whereas classic scrapie
produces a 3 protein band pattern that ranges from 20
to 30 kDa.1 In addition, the Western blot pattern for
classic scrapie after deglycosylation with PNGase has
a distinct change from 3 protein bands to 1 band at
approximately 20 kDa, which corresponds to a single
unglycosylated fragment. This change in the Western
blot pattern does not occur when Nor98 scrapie is
treated with PNGase. The Nor98 banding pattern is
typically unchanged for the fastest migrating bands,
which suggests that they are nonglycosylated.15
Scrapie was first recognized in the United States in
1947, and, since 1952, the U.S. Department of
Agriculture (USDA) has worked to control and
eradicate this disease (USDA, APHIS, VS: 2004,
Scrapie). Currently, the USDA conducts surveillance
designed to identify scrapie-infected flocks and uses a
genetic-based approach to determine which scrapieexposed sheep are depopulated or restricted. From
2002 to 2003, a national scrapie surveillance study
was conducted to determine the prevalence of scrapie
in mature cull ewes. More than 12,000 ewes were
examined, and the results indicated the estimated
national prevalence of scrapie in mature ewes to be
0.20%, with the majority of positive animals being
black-faced sheep (U.S. Department of Agriculture,
Animal and Plant Health Inspection Service, Veterinary Services, National Animal Health Monitoring
System: 2004, Phase II: Scrapie: ovine slaughter
surveillance study 2002–2003, http://nahms.aphis.
usda.gov/sheep/SOSSphase2.pdf. Accessed on December 17, 2008). Results of ongoing surveillance
indicate that this eradication program is succeeding,
as shown by a steady decrease in disease prevalence in
this population. The U.S. National Scrapie Eradication Program includes slaughter surveillance, live
animal testing, animal identification requirements,
flock-based disease control programs, and other
measures to eradicate scrapie from the United States
(USDA, APHIS, VS: 2004, Scrapie).
A key component of the eradication program is the
identification of preclinical infected sheep through
live-animal testing and slaughter surveillance. Regulatory scrapie slaughter surveillance (RSSS) targets
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mature, healthy appearing sheep and goats that meet
specific criteria based on phenotype (face color in
sheep) and age, as well as sheep and goats with
suspicious clinical signs, including behavioral
changes, head and neck tremors, rubbing, and
incoordination that progresses to recumbency and
death. Specimens from these targeted animals are
collected primarily at slaughter facilities; in addition,
some specimens are collected from dead, disabled, or
suspect animals found at other concentration points.
Approximately 44,000 sheep and goats are expected
to be sampled in fiscal year 2008 (October 1, 2007
through September 30, 2008).
Any scrapie-infected animals identified by these
programs are then traced to their flock of origin,
which results in the removal of scrapie-infected and
genetically susceptible exposed animals. The number
of animals removed from on-farm sampling, including suspect, genetically susceptible exposed, and
potentially exposed animals, is expected to total
approximately 2,300 in fiscal year 2008. It was
through these ongoing efforts of surveillance that
scrapie cases consistent with the Nor98 strain were
found. The current study describes the diagnostic
findings of the first 6 cases of Nor98 scrapie in sheep
of the United States.
Materials and methods
Case material
Fixed brain tissue, including caudal brainstem and
cranial cervical spinal cord; fixed lymphoid tissue, including retropharyngeal lymph node (cases 1–6), tonsil (cases 1,
5), and rectal submucosa (case 1); paraffin blocks that
contained brain and lymphoid tissue; and, when available,
fresh brain tissue limited to cerebellum were submitted to
the National Veterinary Services Laboratories (NVSL)
Pathobiology Laboratory (Ames, IA) for diagnostic
confirmation of scrapie.
Histopathology
Caudal brainstem and cranial cervical spinal cord for
each of the 6 cases was submitted in 10% buffered formalin.
Cerebellum, submitted fresh for cases 1, 2, 4, and 5, was
also placed in 10% buffered formalin for further evaluation. After adequate fixation, all of these tissues were
embedded in paraffin wax, sectioned at 5-mm thickness,
stained with hematoxylin and eosin (HE), and examined by
light microscopy (Table 1).
Immunohistochemistry
Samples of brain, spinal cord, and lymph tissue from
each animal were placed in 10% buffered formalin,
embedded in paraffin wax, sectioned at 5-mm thickness,
and processed for IHC evaluation. A previously described
automated IHC method with several modifications was
used for detection of PrPSc.21 Briefly, the tissue sections
were placed on glass slides, dried in an 80uC oven,
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Table 1.

Diagnostic results of 6 U.S. sheep with Nor98 scrapie.*
ELISA TSE sheep and
goat kitk

Immunohistochemistry
Case no.

Age
(years)

1

Aged{

2

8

31

16

4

8{

5

3{

61

4

Genotype
136-141154-171 SNTN DMNV

AA FL
RR QQ
AA LL
RR RR
AA LL
RR QQ
AA LL
RH QQ
AA FL
RR QQ
AA FL
RR QQ

Lymphoid
Cerebellum Spinal cord
tissue{

Western
blotf

ELISA scrapie antigen kitl

Cerebellum

Brain
stem

Cerebellum

Brain stem

+

2

2

+

2

+

+

+

2

2

+

2

+

+

2

+

+

NA

+

NA

+

2

NA

+

2

NA

NA

NA

NA

NA

+

2

+

+

2

+

+

NA

2

NA

+

2

+

+

2

+

+

+

+

2

+

2

NA

+

2

NA

NA

NA

NA

NA

* SNTN 5 spinal nucleus of the trigeminal nerve; DMNV 5 dorsal motor nucleus of the vagus nerve; ELISA 5 enzyme-linked
immunosorbent assay; TSE 5 transmissible spongiform encephalopathy; + 5 positive; 2 5 negative; NA 5 not available.
{ Retropharyngeal lymph node (cases 1–6), tonsil (cases 1, 5), rectal submucosa (case 1).
{ Age was approximated.
1 Fresh tissue was not available.

deparaffinized, rehydrated, and incubated in 95% formic
acid for 5 min. After washes in Tris buffer and water, the
slides were immersed in antigen retrieval buffera and placed
in a commercially available antigen retrieval deviceb for 20
min at 121uC. After the slides were cooled to room
temperature, they were stained by using an automated
immunostainer.c The primary antibody used was the PrPspecific antibody, F99/97.6.1.d Detection was performed by
using a biotin-free, multimer-based alkaline phosphatase
system.e Sections were counterstained with hematoxylin
and a bluing reagent. Coverslips were then mounted with a
permanent xylene-based mounting medium. Test slides
were examined by light microscopy for lesions and
classified as positive or negative for the presence of PrPSc
(Table 1). Tissues from scrapie-positive sheep were used as
positive controls, and tissue from scrapie-negative sheep
were used as negative controls.
Western blot analyses
Samples were examined by a transmissible spongiform
encephalopathy (TSE) Western blot confirmatory assay kitf
by following the manufacturer’s recommendations. Briefly,
20% homogenates of fresh brain tissue were prepared for
the 4 cases that had fresh tissue available for testing. The
samples were homogenized, purified, and treated with
proteinase K; PrPSc was then concentrated and solubilized
in 100 ml Laemmli solution that contained 5% (v/v)
mercaptoethanol and 2% (w/v) sodium dodecyl sulfate.
After centrifugation, the supernatants were heated at 100uC
for 5 min before electrophoresis. The proteins were
transferred onto polyvinylidene fluoride membranesg (115
V for 60 min) and blocked for 30 min at room temperature.
The kit’s primary antibody (monoclonal antibody SHA31,
diluted to 1:10 of the supplied kit concentration) was
applied for 30 min at room temperature. Membranes were
washed, incubated for 20 min in the kit’s secondary

antibody at room temperature, washed again, and incubated with an enhanced chemiluminescent substrate.h
Digital images of the blots were produced by using an
image analysis system.i
Sufficient frozen tissue from case 2 was available for
deglycosylation analysis, performed as previously described22 with proteinase K digestion by using 20 mg/ml
for 30 min at 37uC. Membranes were probed with antibody
L42j and goat anti-mouse immunoglobulin G, F(ab’)2
coupled to horseradish peroxidase.
Enzyme-linked immunosorbent assay
Enzyme-linked immunosorbent assay (ELISA) testing
was performed by using 2 commercially available ELISA
test kits. The TSE sheep and goat detection kitk was used
according to the manufacturer’s recommendations. Briefly,
20% homogenates of fresh brain tissue were prepared for
the 4 cases that had fresh tissue available. After purification, treatment with proteinase K, and concentration of
PrPSc using the new sample preparator semiautomated
system,g samples were loaded onto a microtiter plate that
was coated with a PrP-specific monoclonal antibody. The
plate was washed and incubated with the enzyme-conjugated tracer antibody and then washed again. Substrate
was added, and the plate was incubated for 30 min. The
reaction was stopped, and absorbance was measured at 450
mm by using a spectrophotometer. All samples with an
optical density (OD) value ,OD450-reference mean of 4
negative control samples plus a factor of 0.21 were
considered negative. Samples equal to or greater than the
mean of 4 negative controls plus 0.21 were considered
positive.
For the second scrapie antigen ELISA test kit,l each
sample was diluted with a working plate diluent according
to the manufacturer’s recommendations. The samples were
then loaded into the PrPSc-specific antigen-capture plate,
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along with positive and negative controls and were
incubated for 2 hr at room temperature. After washing
the plate and then incubating with the conditioning buffer
(10 min at room temperature), the samples were washed
and incubated with a horseradish peroxidase–conjugated
anti-PrP antibody for 1 hr at room temperature. The
colorimetric signal was developed for 15 min. The reaction
was stopped, and absorbance was measured at 450 mm by
using a spectrophotometer. All samples with an OD value
,OD450-reference mean of 2 negative control samples plus
a factor of 0.18 were considered negative. Samples equal to
or above the mean of 2 negative controls plus 0.18 were
considered positive.

Results
Case 1

The first case identified as consistent with Nor98
scrapie had nonclassic PrPSc distribution in brain
tissue, no PrPSc in lymph tissue, and nonclassic
migration of protein bands on a Western blot test.
The animal was an aged, mottled-faced ewe that was
traced back to a commercial flock in Wyoming.
Individual animal records were not kept on the
premises, so it was impossible to determine how long
the ewe was on the farm, how many times she lambed
on that farm, or her flock of origin. She was taken to
a sale along with 88 other sheep and was tested at
slaughter for scrapie as part of the RSSS program.
No abnormal clinical signs were noted at the time of
sale. The Prnp genotype of the case 1 ewe was AFRQ/
ALRQ (136 AA, 141 FL, 154 RR, 171 QQ).
Evaluation of the brain by using HE revealed no
lesions. IHC highlighted PrPSc bilaterally in the spinal
nucleus of the trigeminal nerve and in the dorsal
aspect of the dorsal horns of the cervical spinal cord
(Fig. 1A, B). There was no PrPSc immunolabeling in
the cerebellum, in the dorsal motor nucleus of the
vagus nerve, or in lymphoid tissue. ELISA results
were positive when using cerebellum and brainstem
by the TSE sheep and goat kitk and negative for the
same tissues when using the scrapie antigen kitl
(Table 1). On Western blot, multiple distinct protein
bands were present, including an unglycosylated band
at ,15 kDa (Fig. 2A, lane 1). Subsequently, the entire
flock was depopulated, and all 317 adult animals
tested negative for Nor98 scrapie and classic scrapie.
Case 2

The second case was a clinically normal 8-year-old
Suffolk ewe that had been in a quarantined flock for 5
years at a USDA facility in Iowa. The USDA flock,
over the 5-year period, contained several hundred
classic scrapie-exposed sheep that had been acquired
over time from numerous private flocks designated as
scrapie-infected or source flocks. A significant portion of the sheep in this quarantined flock ultimately
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died or was euthanized because of classic scrapie. The
ewe and the entire remaining flock of 95 sheep were
euthanized and tested for scrapie at the completion of
a study that evaluated the use of third eyelid tissue for
scrapie testing. The Prnp genotype of the case 2 ewe
was ALRR/ALRR (136 AA, 141 LL, 154 RR, 171
RR). Evaluation of the brain by using HE revealed no
lesions. IHC highlighted PrPSc bilaterally in the spinal
nucleus of the trigeminal nerve (Fig. 1C) and in the
dorsal aspect of the dorsal horns of the cervical spinal
cord. There was also abundant PrPSc immunolabeling
in the cerebellar molecular layer, mild-to-moderate
immunolabeling in the cerebellar granular layer, and
minimal scattered immunolabeling in the cerebellar
white matter (Fig. 1D). PrPSc immunolabeling was
absent from the dorsal motor nucleus of the vagus
nerve and lymphoid tissue. ELISA results were
positive when using cerebellum by both the TSE
sheep and goat kitk and the scrapie antigen kitl
(Table 1). Western blot results included multiple
protein bands with an unglycosylated band at ,15
kDa (Fig. 2B, lanes 3 and 4). Digestion with PNGase
after proteinase K treatment resulted in 3 unglycosylated bands (Fig. 2C, lane 4) comigrating with the
lower 3 bands of the untreated sample (Fig. 2C, lane
3). A classic scrapie sample treated under identical
conditions yielded a single band comigrating with the
lowest band in the untreated sample (Fig. 2C, lanes 1
and 2). All sheep in this USDA-quarantined flock
were tested for scrapie. No additional cases of Nor98
scrapie were detected, whereas 4 cases of classic
scrapie were identified in the remaining 95 sheep.
Case 3

A 16-year-old, white-faced, cross-bred wether was
born to a black-faced ewe. He lived his entire life as a
pet on a farm in California, and was 1 of 6 wethers
purchased as a group at 2 months of age. No other
sheep were kept on the farm before this group, and
none were introduced to the farm after the group was
purchased. No clinical signs suggestive of scrapie
disease were noted. The animal, with a history of
having a large cervical mass, was submitted for
necropsy. Samples were tested for scrapie as part of
the national scrapie surveillance program through the
National Animal Health Laboratory Network. The
necropsy revealed a 15-cm cervical thymoma that had
compressed the esophagus and resulted in aspiration
pneumonia. The Prnp genotype of the case 4 wether
was ALRQ/ALRQ (136 AA, 141 LL, 154 RR, 171
QQ). Evaluation of the brain by using HE revealed no
lesions. IHC highlighted PrPSc bilaterally in the spinal
nucleus of the trigeminal nerve and in the dorsal
aspect of the dorsal horns of the cervical spinal cord
(Fig. 1E). PrPSc immunolabeling in the dorsal motor
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Figure 1. Immunolabeling of PrPSc in selected brain structures of the U.S. Nor98 scrapie–positive sheep. A, spinal-tract nucleus of
the trigeminal nerve, case 1. Bar 5 100 mm. B, dorsal horn of the cervical spinal cord, case 1. Bar 5 200 mm. C, spinal-tract nucleus of the
trigeminal nerve, case 2. Bar 5 100 mm. D, cerebellum, case 2. Bar 5 450 mm. E, dorsal horn of the cervical spinal cord, case 3. Bar 5 200
mm. F, cerebellum, case 4. Bar 5 200 mm. G, cerebellum, case 5. Bar 5 200 mm. H, spinal-tract nucleus of the trigeminal nerve case 6. Bar
5 100 mm.

Nor98 scrapie in the United States

459

Figure 2. Western immunoblot analysis of U.S. Nor98 scrapie–positive sheep. PrPSc in proteinase K–digested brain tissue
homogenates. A, lane 1: U.S. Nor98 case 1; lane 2: molecular marker; 3 5 classic scrapie negative control; lane 4: Nor98 positive control.
B, lane 1: classic scrapie positive control; lane 2: molecular marker; lanes 3, 4: U.S. Nor98 case 2. C, lane 1: classic scrapie positive
control without PNGase; lane 2: classic scrapie positive control with PNGase treatment; lane 3: U.S. Nor98 case 2 without PNGase; lane
4: U.S. Nor98 case 2 with PNGase treatment. D, lane 1: classic scrapie positive control; lane 2; bovine spongiform encephalopathy (BSE)
positive control; lane 3: molecular marker; lane 4: Nor98 positive control; lane 5: molecular marker; lane 6: U.S. Nor98 case 4; lane 7:
molecular marker. E, lane 1: molecular marker; lane 2: classic scrapie positive control; lane 3: BSE positive control; lane 4: U.S. Nor98
case 5; lane 5: molecular marker. Arrow in each panel represents 30 kDa.

nucleus of the vagus nerve and in lymphoid tissue was
absent. The cerebellum was unavailable for evaluation. ELISA and Western blot tests were not done,
because fresh tissue was unavailable. Brain samples
were available from one other aged flock mate, and
all tests were negative for Nor98 and classic scrapie.
Case 4

The fourth case of Nor98 scrapie was identified in
an approximately 8-year-old Dorset ewe that was
born into a flock of approximately 20 ewes in
Indiana. After a flock dispersal sale, the ewe went
to slaughter and was tested for scrapie as part of the

RSSS program. No clinical signs suggestive of scrapie
disease were noted. The Prnp genotype of the case 4
ewe was ALRQ/ALHQ (136 AA, 141 LL, 154 RH,
171 QQ). Evaluation of the brain by using HE
revealed no lesions. IHC highlighted PrPSc bilaterally
in the spinal nucleus of the trigeminal nerve and in the
dorsal aspect of the dorsal horns of the cervical spinal
cord. There was abundant PrPSc immunolabeling in
the cerebellar molecular layer, moderate immunolabeling in the cerebellar granular layer, and minimal
scattered immunolabeling in the cerebellar white
matter (Fig. 1F), and no PrPSc immunolabeling in
the dorsal motor nucleus of the vagus nerve or in
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lymphoid tissue. The ELISA results were positive for
cerebellum by the TSE sheep and goat kitk and
negative for the same tissue when using the scrapie
antigen kitl (Table 1). Western blot results included
multiple protein bands with an unglycosylated band
at ,15 kDa (Fig. 2D, lane 6). Based on sale records,
all of the animals sold at the dispersal sale went to
slaughter, thus, no additional animals were available
for scrapie testing.
Case 5

The fifth case was a clinically normal, approximately 3-year-old, white-faced, cross-bred ewe from
an approximately 400 head commercial flock in
Minnesota. The ewe was euthanized and tested for
scrapie because the flock had previously been
identified as a classic scrapie–infected flock. The Prnp
genotype of the case 5 ewe was AFRQ/ALRQ (136
AA, 141 FL, 154 RR, 171 QQ). Evaluation of the
brain by using HE revealed no lesions. IHC
highlighted PrPSc bilaterally in the spinal nucleus of
the trigeminal nerve and in the dorsal aspect of the
dorsal horns of the cervical spinal cord. Abundant
PrPSc immunolabeling was present in the cerebellar
molecular layer, mild immunolabeling in the cerebellar granular layer, and minimal scattered immunolabeling in the cerebellar white matter (Fig. 1G).
PrPSc immunolabeling in the dorsal motor nucleus of
the vagus nerve and in lymphoid tissue was absent.
The ELISA results were positive when using cerebellum by both the TSE sheep and goat kitk and the
scrapie antigen kitl (Table 1). When using brainstem,
ELISA was positive by the TSE sheep and goat kitk
and negative by the scrapie antigen kitl (Table 1).
Western blot produced multiple protein bands,
including an unglycosylated band at ,15 kDa
(Fig. 2E, lane 4). The flock was depopulated, and
no additional cases of Nor98 or classic scrapie were
identified in the adult sheep.
Case 6

The sixth case of Nor98 scrapie was identified in a
4-year-old, white-faced ewe that was purchased and
added to a commercial flock in Pennsylvania that
consisted of approximately 700 head of sheep and
goats. Individual animal records were not kept on the
premises, so it was impossible to determine exactly
how long the ewe was on the farm or her flock of
origin. It was estimated that she remained in this flock
for approximately 1 month, was sent to slaughter,
and was tested for PrPSc as part of the RSSS program.
No clinical signs suggestive of scrapie disease were
noted. The Prnp genotype of the case 6 ewe was
AFRQ/ALRQ (136 AA, 141 FL, 154 RR, 171 QQ).
Evaluation of the brain by using HE revealed no

lesions. IHC highlighted PrPSc bilaterally in the spinal
nucleus of the trigeminal nerve (Fig. 1H) and in the
dorsal aspect of the dorsal horns of the cervical spinal
cord. PrPSc immunolabeling in the dorsal motor
nucleus of the vagus nerve and in lymphoid tissue
was absent. Cerebellum was unavailable for evaluation. ELISA and Western blot tests were not done
because fresh tissue was unavailable. The commercial
flock was depopulated, and adult animals exposed to
this ewe were tested for scrapie. No additional cases
of Nor98 or classic scrapie were identified. A
summary of relevant findings from all cases is shown
in Table 1.
Discussion
Nor 98-like scrapie has significantly different
diagnostic features when compared with classic
scrapie.1,10 In the past, classic scrapie disease was
confirmed by examination of the brain tissue for a
triad of salient histopathologic changes, including
vacuolation limited to gray matter referred to as
spongiform change, loss of neurons, and accompanying gliosis.26 However, more recently, a presumptive
histopathologic diagnosis was largely replaced by the
more sensitive and confirmatory IHC and biochemical methods for detection of PrPSc in the brain or
lymphoid tissues. In the case of Nor98 scrapie, there
is generally little or no vacuolation in the brain, and,
to date, no lymphoid accumulation of PrPSc has been
detected.1 Classic scrapie has the earliest and most
intense PrPSc immunolabeling at the motor nucleus of
the vagus nerve as well as often abundant immunolabeling in numerous areas that contained lymphoid
tissue, including retropharyngeal lymph nodes, tonsil,
third eyelid, and rectal submucosa. Conversely,
Nor98 scrapie–infected animals have no immunolabeling for PrPSc in the motor nucleus of the vagus
nerve or in lymphoid tissues, but there typically is
immunolabeling for PrPSc in the spinal nucleus of the
trigeminal nerve and variable but often intense,
immunolabeling for PrPSc in the cerebellum.1 Thus,
the diagnosis of Nor98 disease can be based on IHC
identification of PrPSc in specific regions of the brain,
primarily the spinal nucleus of the trigeminal nerve
and the cerebellum (Fig. 1) if there is a concurrent
lack of immunolabeling for PrPSc in the dorsal motor
nucleus of the vagus nerve or in any lymphoid tissues.
In addition, there is a distinct diagnostic Western blot
pattern for Nor98 scrapie that consists of multiple
protein bands, including an unglycosylated band at
,15 kDa. This pattern remains unchanged for the
lower 2–3 bands after enzymatic deglycosylation and
is distinct from classic scrapie, in which the 3 protein
bands that range from 20 to 30 kDa are reduced to a
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single unglycosylated 20 kDa band after treatment
with PNGase.1,10,15
Nor98 scrapie was diagnosed in each of the 6 cases
described in the present study based on IHC results
(Table 1). In 4 of the cases that included fresh tissue,
Western blot and ELISA results supported the
diagnosis. All 6 cases had striking IHC features,
including positive PrPSc immunolabeling in the spinal
nucleus of the trigeminal nerve and positive PrPSc
immunolabeling in the dorsal horns of the cervical
spinal cord (Fig. 1). Positive PrPSc immunolabeling
was less consistent in sections of cerebellum in the 4
cases that included this tissue for evaluation. Three of
the 4 cases that included cerebellum were strongly
positive with a similar distribution of PrPSc. The
majority of PrPSc immunolabeling was present in the
cerebellar molecular layer. Low-to-moderate PrPSc
immunolabeling was present in the cerebellar granular layer, with only minimal scattered immunolabeling in the cerebellar white matter. The Purkinje cells
were negative for immunolabeling in each of these
cases. The fourth case, including cerebellum had no
PrPSc immunolabeling present. None of the 6 cases
had PrPSc immunolabeling in the dorsal motor
nucleus of the vagus nerve, and none had PrPSc
immunolabeling in lymphoid tissues. Western blot
produced similar results for the 4 cases that had fresh
tissue available for testing. In each case, there were
multiple protein bands, including an unglycosylated
band that measured ,15 kDa (Fig 2A, lane 1; B,
lanes 3 and 4; D, lane 6; E, lane 4). A distinct feature
in the analysis of Nor98 scrapie by Western blot
testing is the presence of 3 different unglycosylated
bands after PNGase treatment15 as observed in case
2 (Fig. 2C, lane 4), whereas, with classic scrapie, just
1 band is detected (Fig. 2C, lane 2). ELISA results
were positive by the TSE sheep and goat kitk for all
4 cases that included fresh tissue but were positive
by the scrapie antigen kitl for only 2 of these cases
(Table 1).
The 6 U.S. cases were identified in a variety of
testing scenarios that ranged from routine slaughter
surveillance of healthy appearing animals to surveillance testing in an aged animal diagnosed with
thoracic neoplasia and secondary pneumonia. None
of the 6 cases had a clinical history that suggested the
presence of a TSE. This is consistent with the findings
in many European countries that have found Nor98
disease on a regular basis through slaughter surveillance of apparently healthy animals and fallen stock.1
Three of the sheep (cases 1, 4, and 6) were identified
through the RSSS program. Of the remaining 3
animals, 2 sheep (cases 2 and 5) were found in flocks
in which classic scrapie had been previously diagnosed, and the last case (case 3, a 16-year-old
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California wether) was presented for a routine
diagnostic necropsy in which scrapie testing was
included. Clinical signs are uncommon in the Nor98
strain of scrapie but most often include ataxia without
pruritis, which is more commonly associated with
classic scrapie.2 None of the 6 sheep described in the
present study were reported to have had clinical signs,
but it might be that subtle signs were not detected.
This is a possibility with cases 1, 4, 5, and 6, because
they were each part of large flocks with high rates of
turnover. With regard to case 3, signs, including
ataxia, may have been masked by other clinical signs
associated with the unrelated disease processes of
pneumonia and an obstructing tumor. Clinical signs
in case 2 were unlikely to be missed, because the
animal was closely scrutinized for scrapie signs as part
of a scrapie study flock. Both Nor98 and classic
scrapie can be diagnosed in a wide variety of age
groups, but Nor98 appears to be more commonly
found in older animals. In contrast to classic scrapie,
which was diagnosed most commonly in 3–5-year-old
sheep, Nor98 scrapie was found most frequently in
animals more than 5 years of age.17 The U.S. cases
described in the current report ranged in age from
approximately 3 to 16 years, with a mean age of 7.8
years.
The 3 codons of the ovine Prnp gene at positions
136, 154, and 171, which are consistently reported to
influence classic scrapie disease,14 also appear to have
some influence on Nor98 scrapie. Sheep with
genotypes known to be underrepresented in the
classic scrapie-infected population are not spared
from the Nor98 strain. Nor98 scrapie has been found
in sheep that carry the A136H154Q171 haplotypes (A 5
alanine, H 5 histidine, and Q 5 glutamine) known to
be less susceptible to classic scrapie and in sheep that
carry the A136R154R171 haplotype (R 5 arginine)
known to be associated with natural resistance to
classic scrapie.8,16 Case 4 in the current study had the
AHQ haplotype, and case 2 was homozygous for the
ARR allele. The V136R154Q171 haplotype (V 5 valine)
has been associated with higher susceptibility to
classic scrapie but seems to offer at least partial
resistance to Nor98 scrapie.14,16,17,24 None of the 6
cases reported in the present study had the VRQ
haplotype. In addition, a fourth codon at position 141
has been identified that also appears to influence the
presence of Nor98 scrapie disease.18 When phenylalanine (F) is present at position 141 with the ARQ
haplotype (AF141RQ), the risk for developing Nor98
scrapie is highest, particularly when a sheep has 2 of
this particular allele or has 1 AHQ allele along with
the AFRQ allele.17,18,24 Cases 1, 5, and 6 presented in
the current study each had an AFRQ haplotype with
F residue at the 141 codon. Of the 6 cases presented, 4
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had susceptible alleles. Cases 1, 5, and 6 had the
AFRQ haplotype, and case 4 had the AHQ haplotype. Furthermore, case 2 had the ARR alleles
reported to be susceptible to Nor98 scrapie but
resistant to classic scrapie. In total, 5 of the 6 sheep
identified in the current study had genotypes consistent with susceptibility to Nor98 scrapie. The sixth
case, case 3, is homozygous for the ALRQ allele,
which has been reported to be present in the Nor98
scrapie–infected population but is considered to have
a low risk of susceptibility.17,18
The incidence of Nor98 scrapie is also reportedly
different from that of classic scrapie. In a study that
included 104 scrapie-infected flocks in Germany, the
incidence of Nor98 scrapie was 0.2%, whereas the
incidence of classic scrapie was 1.7%.17 The same
study also found that, in more than 90% of the flocks
infected with Nor98 scrapie, there was only a single
infected animal within the flock. Similarly, each of the
U.S. Nor98-positive animals was the only animal
identified in their respective flock with this unique
strain of scrapie. In another study that compared the
prevalence of classic scrapie and Nor98 scrapie in 20
European countries, it was reported that, although
the overall prevalence was low for both classic and
Nor98 scrapie, there was greater variation in the
prevalence of classic scrapie. Nor98 scrapie was
relatively consistently present in all countries that
participated in the study.12 Given this information
and when considering how closely the 6 U.S. cases of
Nor98 scrapie reported herein parallel European
cases with regard to epidemiology and pathology, it
is likely that a low but relatively consistent prevalence
of Nor98 scrapie will be found wherever rigorous
surveillance occurs.
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